5 mg prednisone
VCRC 5526B TAPIR
Phase 3 small_molecule active
Quick answer
5 mg prednisone for Granulomatosis With Polyangiitis is a Phase 3 program (small_molecule) at Ultragenyx Pharmaceutical with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx Pharmaceutical
- Indication
- Granulomatosis With Polyangiitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active